Products & Technology

Theramx Inc.

Creating Value for the World

AI-based Brainwave Diagnosis (EEG) Technology

  •  
  • Products & Technology
  • AI-based Brainwave Diagnosis

Technology that excavates biomarkers through an analysis of brainwaves in epilepsy or Alzheimer’s patients, predicts the likelihood of onset, or diagnoses the advance, based on the degree of change of brainwave biomarkers measured by a wearable EEG (AI-electroencephalogram) measuring instrument allowing.

  • Overview
    Theramx retains AI-based technology that allows brainwave analysis for prediction, diagnosis of epilepsy or Alzheimer and discovery of biomarkers, as well as development competency for AI-based prediction software. Based on such proficiency, Theramx is developing AI-prediction software interface and non-invasive wearable EEG device optimized for epilepsy and Alzheimer’s biomarkers, distinguished from the conventional device which is limited to detective functions only.
  • Development Schedules

    * You can view it by scrolling left or right.

    Platform Name Indication Model No. Development Plans
    2021 2022 2023 2024 2025 2026
    TRAZ-EP-AI Epilepsy TR-EP-H-01

    TR-EP-P-01

    TRAZ-EP-AI-CON TR-EP-C-01

    Platform Name Indication Model No. Development Plans
    2021 2022 2023 2024 2025 2026
    TRAZ-ALZ-AI
    System    		 Alzheimer’s TR-AL-H-01

    TR-AL-P-01

    Development and Certification

    Product Launch